Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Maria A Papathanasopolous

Low Rates of Nucleoside Reverse Transcriptase Inhibitor Resistance in a Well-Monitored Cohort in South Africa on Antiretroviral Therapy

Antiviral Therapy
Infectious DiseasesPharmacology
2011English

Related publications

Non-Nucleoside Reverse Transcriptase Inhibitor Outcomes Among Combination Antiretroviral Therapy-Treated Adults in Botswana

AIDS
Infectious DiseasesAllergyImmunology
2010English

Multicenter Study of Skin Rashes and Hepatotoxicity in Antiretroviral-Naïve HIV-positive Patients Receiving Non-Nucleoside Reverse-Transcriptase Inhibitor Plus Nucleoside Reverse-Transcriptase Inhibitors in Taiwan

PLoS ONE
Multidisciplinary
2017English

Antiretroviral Therapy: Reverse Transcriptase Inhibition.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients With Nucleoside Reverse Transcriptase Inhibitor Resistance

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2018English

Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients

AIDS Research and Treatment
ImmunologyPublic HealthAllergyEnvironmentalDermatologyInfectious DiseasesOccupational Health
2015English

Age in Antiretroviral Therapy Programmes in South Africa: A Retrospective, Multicentre, Observational Cohort Study

The Lancet HIV
EpidemiologyInfectious DiseasesImmunologyVirology
2015English

First-Line Antiretroviral Therapy With a Protease Inhibitor Versus Non-Nucleoside Reverse Transcriptase Inhibitor and Switch at Higher Versus Low Viral Load in HIV-infected Children: An Open-Label, Randomised Phase 2/3 Trial

The Lancet Infectious Diseases
Infectious Diseases
2011English

Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy Without Resistance in a Large HIV Treatment Program in South Africa

PLoS ONE
Multidisciplinary
2012English

Pharmaceutical, Clinical, and Resistance Information on Doravirine, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection

Drugs in Context
Molecular MedicinePharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy